New therapy shrinks tumors to treat lung cancer. The need for more effective lung cancer treatments is paramount, as the disease remains a leading cause of cancer deaths in the United States.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: The need for more effective lung cancer treatments is paramount, as the disease remains a leading cause of cancer deaths in the United States. New findings by a research team from the Stony Brook Cancer Center highlight a novel therapeutic shown to be highly effective in reducing non-small cell lung cancer (NSCLC) tumors and appearing to halt drug resistance in a laboratory model.
- Ponto de atenção: therapy.
- Ponto de atenção: shrinks.
- Ponto de atenção: tumors.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Saúde.
